{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:43:47Z","timestamp":1794008627339,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.82270804, No.82470792"],"award-info":[{"award-number":["No.82270804, No.82470792"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"crossref","award":["No.2025DJA009, No.2023AFB867"],"award-info":[{"award-number":["No.2025DJA009, No.2023AFB867"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Young Elite Scientists Sponsorship Program by CAST","award":["No. YESS20220646"],"award-info":[{"award-number":["No. YESS20220646"]}]},{"DOI":"10.13039\/100016804","name":"Shenzhen Natural Science Foundation","doi-asserted-by":"crossref","award":["No. JCYJ20230807143505011, 202506043006900"],"award-info":[{"award-number":["No. JCYJ20230807143505011, 202506043006900"]}],"id":[{"id":"10.13039\/100016804","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04455-6","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:35:25Z","timestamp":1777264525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Engineered T cell membrane coated nanoparticles reverse thermo-resistance and reprogram tumor microenvironment to synergistically potentiate bladder cancer photothermal immunotherapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Zichen","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhuo","family":"Ba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongke","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"4455_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"4455_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20:287\u2013304.","journal-title":"Nat Rev Clin Oncol"},{"key":"4455_CR3","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;384:e076743.","journal-title":"BMJ"},{"key":"4455_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S1470-2045(17)30065-7","volume":"18","author":"P Sharma","year":"2017","unstructured":"Sharma P, Retz M, Siefker-Radtke A, Baron A, Necchi A, Bedke J, Plimack ER, Vaena D, Grimm MO, Bracarda S, et al. Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2017;18:312\u201322.","journal-title":"Lancet Oncol"},{"key":"4455_CR5","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18:792\u2013804.","journal-title":"Nat Rev Clin Oncol"},{"key":"4455_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yue X, Chen Z, Liu C, Wu W, Zhang N, Liu Z, Yang L, Jiang Q, Cheng Q, et al. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol Cancer. 2023;22:159.","journal-title":"Mol Cancer"},{"key":"4455_CR7","doi-asserted-by":"publisher","first-page":"eadg3840","DOI":"10.1126\/scitranslmed.adg3840","volume":"16","author":"JJF Sleeboom","year":"2024","unstructured":"Sleeboom JJF, van Tienderen GS, Schenke-Layland K, van der Laan LJW, Khalil AA, Verstegen MMA. The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets. Sci Transl Med. 2024;16:eadg3840.","journal-title":"Sci Transl Med"},{"key":"4455_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141:52\u201367.","journal-title":"Cell"},{"key":"4455_CR9","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1124\/pharmrev.121.000349","volume":"74","author":"LGN de Almeida","year":"2022","unstructured":"de Almeida LGN, Thode H, Eslambolchi Y, Chopra S, Young D, Gill S, Devel L, Dufour A. Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology. Pharmacol Rev. 2022;74:712\u201368.","journal-title":"Pharmacol Rev"},{"key":"4455_CR10","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1136\/gutjnl-2023-331342","volume":"73","author":"N Cai","year":"2024","unstructured":"Cai N, Cheng K, Ma Y, Liu S, Tao R, Li Y, Li D, Guo B, Jia W, Liang H, et al. Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8(+) T cell-mediated antitumour immunity and improves anti-PD-1 efficacy. Gut. 2024;73:985\u201399.","journal-title":"Gut"},{"key":"4455_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","volume":"17","author":"X Li","year":"2020","unstructured":"Li X, Lovell JF, Yoon J, Chen X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol. 2020;17:657\u201374.","journal-title":"Nat Rev Clin Oncol"},{"key":"4455_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12943-023-01798-8","volume":"22","author":"P Kesharwani","year":"2023","unstructured":"Kesharwani P, Ma R, Sang L, Fatima M, Sheikh A, Abourehab MAS, Gupta N, Chen ZS, Zhou Y. Gold nanoparticles and gold nanorods in the landscape of cancer therapy. Mol Cancer. 2023;22:98.","journal-title":"Mol Cancer"},{"key":"4455_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41568-018-0020-9","volume":"18","author":"S Joshi","year":"2018","unstructured":"Joshi S, Wang T, Araujo TLS, Sharma S, Brodsky JL, Chiosis G. Adapting to stress - chaperome networks in cancer. Nat Rev Cancer. 2018;18:562\u201375.","journal-title":"Nat Rev Cancer"},{"key":"4455_CR14","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/s41416-022-01896-2","volume":"127","author":"R Huang","year":"2022","unstructured":"Huang R, Li S, Tian C, Zhou P, Zhao H, Xie W, Xiao J, Wang L, Habimana JD, Lin Z, et al. Thermal stress involved in TRPV2 promotes tumorigenesis through the pathways of HSP70\/27 and PI3K\/Akt\/mTOR in esophageal squamous cell carcinoma. Br J Cancer. 2022;127:1424\u201339.","journal-title":"Br J Cancer"},{"key":"4455_CR15","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.1038\/s41467-023-40300-2","volume":"14","author":"M Yan","year":"2023","unstructured":"Yan M, Chen Q, Liu T, Li X, Pei P, Zhou L, Zhou S, Zhang R, Liang K, Dong J, et al. Site-selective superassembly of biomimetic nanorobots enabling deep penetration into tumor with stiff stroma. Nat Commun. 2023;14:4628.","journal-title":"Nat Commun"},{"key":"4455_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","volume":"23","author":"L Galluzzi","year":"2024","unstructured":"Galluzzi L, Guilbaud E, Schmidt D, Kroemer G, Marincola FM. Targeting immunogenic cell stress and death for cancer therapy. Nat Rev Drug Discov. 2024;23:445\u201360.","journal-title":"Nat Rev Drug Discov"},{"key":"4455_CR17","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","volume":"57","author":"M Ma","year":"2024","unstructured":"Ma M, Jiang W, Zhou R. DAMPs and DAMP-sensing receptors in inflammation and diseases. Immunity. 2024;57:752\u201371.","journal-title":"Immunity"},{"key":"4455_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","volume":"24","author":"P Meier","year":"2024","unstructured":"Meier P, Legrand AJ, Adam D, Silke J. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity. Nat Rev Cancer. 2024;24:299\u2013315.","journal-title":"Nat Rev Cancer"},{"key":"4455_CR19","first-page":"522","volume":"5","author":"A Jin","year":"2020","unstructured":"Jin A, Wang Y, Lin K, Jiang L. Nanoparticles modified by polydopamine: Working as drug carriers. Bioact Mater. 2020;5:522\u201341.","journal-title":"Bioact Mater"},{"key":"4455_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12951-021-01131-9","volume":"19","author":"M Zhu","year":"2021","unstructured":"Zhu M, Shi Y, Shan Y, Guo J, Song X, Wu Y, Wu M, Lu Y, Chen W, Xu X, Tang L. Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics. J Nanobiotechnol. 2021;19:387.","journal-title":"J Nanobiotechnol"},{"key":"4455_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.tips.2019.03.002","volume":"40","author":"P Noel","year":"2019","unstructured":"Noel P, Von Hoff DD, Saluja AK, Velagapudi M, Borazanci E, Han H. Triptolide and Its Derivatives as Cancer Therapies. Trends Pharmacol Sci. 2019;40:327\u201341.","journal-title":"Trends Pharmacol Sci"},{"key":"4455_CR22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12951-022-01389-7","volume":"20","author":"R Sun","year":"2022","unstructured":"Sun R, Dai J, Ling M, Yu L, Yu Z, Tang L. Delivery of triptolide: a combination of traditional Chinese medicine and nanomedicine. J Nanobiotechnol. 2022;20:194.","journal-title":"J Nanobiotechnol"},{"key":"4455_CR23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12951-021-01095-w","volume":"19","author":"Z Li","year":"2021","unstructured":"Li Z, Yang G, Han L, Wang R, Gong C, Yuan Y. Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma. J Nanobiotechnol. 2021;19:360.","journal-title":"J Nanobiotechnol"},{"key":"4455_CR24","doi-asserted-by":"publisher","first-page":"7979","DOI":"10.1021\/acsnano.3c00891","volume":"17","author":"M Overchuk","year":"2023","unstructured":"Overchuk M, Weersink RA, Wilson BC, Zheng G. Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine. ACS Nano. 2023;17:7979\u20138003.","journal-title":"ACS Nano"},{"key":"4455_CR25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun L, Liu H, Ye Y, Lei Y, Islam R, Tan S, Tong R, Miao YB, Cai L. Smart nanoparticles for cancer therapy. Signal Transduct Target Ther. 2023;8:418.","journal-title":"Signal Transduct Target Ther"},{"key":"4455_CR26","doi-asserted-by":"publisher","first-page":"e2405417","DOI":"10.1002\/smll.202405417","volume":"21","author":"Y He","year":"2025","unstructured":"He Y, Peng E, Ba X, Wu J, Deng W, Huang Q, Tong Y, Shang H, Zhong Z, Liu X, et al. ROS Responsive Cerium Oxide Biomimetic Nanoparticles Alleviates Calcium Oxalate Crystals Induced Kidney Injury via Suppressing Oxidative Stress and M1 Macrophage Polarization. Small. 2025;21:e2405417.","journal-title":"Small"},{"key":"4455_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12951-025-03511-x","volume":"23","author":"W Deng","year":"2025","unstructured":"Deng W, Chen Y, Bai Y, Shang H, Wu J, Zhong Z, Ba X, Tong Y, He Y, Jiang K, Tang K. Genetically engineered T cell membrane-camouflaged nanoparticles triggered cuproptosis for synergistic bladder cancer photothermal-immunotherapy. J Nanobiotechnol. 2025;23:425.","journal-title":"J Nanobiotechnol"},{"key":"4455_CR28","doi-asserted-by":"publisher","first-page":"19599","DOI":"10.1021\/acsnano.4c17444","volume":"19","author":"H Shang","year":"2025","unstructured":"Shang H, Xia D, Geng R, Wu J, Deng W, Tong Y, Ba X, Zhong Z, He Y, Huang Q, et al. Thermosensitive Resiquimod-Loaded Lipid Nanoparticles Promote the Polarization of Tumor-Associated Macrophages to Enhance Bladder Cancer Immunotherapy. ACS Nano. 2025;19:19599\u2013621.","journal-title":"ACS Nano"},{"key":"4455_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","volume":"20","author":"RH Fang","year":"2023","unstructured":"Fang RH, Gao W, Zhang L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Rev Clin Oncol. 2023;20:33\u201348.","journal-title":"Nat Rev Clin Oncol"},{"key":"4455_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jconrel.2022.04.019","volume":"346","author":"N Dhas","year":"2022","unstructured":"Dhas N, Garc\u00eda MC, Kudarha R, Pandey A, Nikam AN, Gopalan D, Fernandes G, Soman S, Kulkarni S, Seetharam RN, et al. Advancements in cell membrane camouflaged nanoparticles: A bioinspired platform for cancer therapy. J Control Release. 2022;346:71\u201397.","journal-title":"J Control Release"},{"key":"4455_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri.2017.108","volume":"18","author":"AH Sharpe","year":"2018","unstructured":"Sharpe AH, Pauken KE. The diverse functions of the PD1 inhibitory pathway. Nat Rev Immunol. 2018;18:153\u201367.","journal-title":"Nat Rev Immunol"},{"key":"4455_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12951-025-03091-w","volume":"23","author":"X Hao","year":"2025","unstructured":"Hao X, Tang Y, Xu W, Wang M, Liu J, Li Y, He J, Peng Y, Sun P, Liao D, et al. Engineered biomimetic cisplatin-polyphenol nanocomplex for chemo-immunotherapy of glioblastoma by inducing pyroptosis. J Nanobiotechnol. 2025;23:14.","journal-title":"J Nanobiotechnol"},{"key":"4455_CR33","doi-asserted-by":"publisher","first-page":"123433","DOI":"10.1016\/j.biomaterials.2025.123433","volume":"323","author":"H Guo","year":"2025","unstructured":"Guo H, Huang G, Long H, Wu W, Lin K, Qiao B, Zhang N, Huang T, Tan Y, Zhang Q, et al. Harnessing PD-1-overexpressing macrophage membrane for preparation of lenvatinib-loaded vesicles to boost immunotherapy against HCC recurrence after radiofrequency ablation. Biomaterials. 2025;323:123433.","journal-title":"Biomaterials"},{"key":"4455_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, Kamada T, Irie T, Okumura G, Kono H, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell. 2022;40:201\u2013e218209.","journal-title":"Cancer Cell"},{"key":"4455_CR35","doi-asserted-by":"publisher","first-page":"eadf4098","DOI":"10.1126\/sciadv.adf4098","volume":"9","author":"N Yin","year":"2023","unstructured":"Yin N, Zhang Z, Ge Y, Zhao Y, Gu Z, Yang Y, Mao L, Wei Z, Liu J, Shi J, Wang Z. Polydopamine-based nanomedicines for efficient antiviral and secondary injury protection therapy. Sci Adv. 2023;9:eadf4098.","journal-title":"Sci Adv"},{"key":"4455_CR36","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/tcr.202000170","volume":"21","author":"J Lu","year":"2021","unstructured":"Lu J, Cai L, Dai Y, Liu Y, Zuo F, Ni C, Shi M, Li J. Polydopamine-Based Nanoparticles for Photothermal Therapy\/Chemotherapy and their Synergistic Therapy with Autophagy Inhibitor to Promote Antitumor Treatment. Chem Rec. 2021;21:781\u201396.","journal-title":"Chem Rec"},{"key":"4455_CR37","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jcis.2021.07.004","volume":"604","author":"H Cao","year":"2021","unstructured":"Cao H, Jiang B, Yang Y, Zhao M, Sun N, Xia J, Gao X, Li J. Cell membrane covered polydopamine nanoparticles with two-photon absorption for precise photothermal therapy of cancer. J Colloid Interface Sci. 2021;604:596\u2013603.","journal-title":"J Colloid Interface Sci"},{"key":"4455_CR38","doi-asserted-by":"publisher","first-page":"eadv6990","DOI":"10.1126\/sciadv.adv6990","volume":"11","author":"Y Gu","year":"2025","unstructured":"Gu Y, Li A, Zeng Y, He M, Qi F, Liu R, Cai H, Li D, Tang X, Fu Z, et al. Engineering hybrid nanoparticles for targeted codelivery of triptolide and CYP3A4-siRNA against pulmonary metastatic melanoma. Sci Adv. 2025;11:eadv6990.","journal-title":"Sci Adv"},{"key":"4455_CR39","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/ptr.8398","volume":"39","author":"M Feng","year":"2025","unstructured":"Feng M, Wu H, Zhu L, Gao J, Deng G. Triptolide Promotes Ferroptosis in Cervical Cancer Cell via NRF2\/xCT\/GPX4. Phytother Res. 2025;39:875\u201387.","journal-title":"Phytother Res"},{"key":"4455_CR40","first-page":"20143","volume":"16","author":"Y Wen","year":"2024","unstructured":"Wen Y, Li K, Ni M, Jiang H, Wu H, Yu Q, Li J, Li X, Wei J, Wu W, Xu H. Dendritic Polylysine with Paclitaxel and Triptolide Codelivery for Enhanced Cancer Ferroptosis through the Accumulation of ROS. ACS Appl Mater Interfaces. 2024;16:20143\u201356.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4455_CR41","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12:860\u201375.","journal-title":"Nat Rev Cancer"},{"key":"4455_CR42","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman I, Chen DS, Powles T, Turley SJ. The cancer-immunity cycle: Indication, genotype, and immunotype. Immunity. 2023;56:2188\u2013205.","journal-title":"Immunity"},{"key":"4455_CR43","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","volume":"56","author":"JR Giles","year":"2023","unstructured":"Giles JR, Globig AM, Kaech SM, Wherry EJ. CD8(+) T cells in the cancer-immunity cycle. Immunity. 2023;56:2231\u201353.","journal-title":"Immunity"},{"key":"4455_CR44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1517\/14728220902832697","volume":"13","author":"L Whitesell","year":"2009","unstructured":"Whitesell L, Lindquist S. Inhibiting the transcription factor HSF1 as an anticancer strategy. Expert Opin Ther Targets. 2009;13:469\u201378.","journal-title":"Expert Opin Ther Targets"},{"key":"4455_CR45","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1038\/s41467-023-39762-1","volume":"14","author":"L Cords","year":"2023","unstructured":"Cords L, Tietscher S, Anzeneder T, Langwieder C, Rees M, de Souza N, Bodenmiller B. Cancer-associated fibroblast classification in single-cell and spatial proteomics data. Nat Commun. 2023;14:4294.","journal-title":"Nat Commun"},{"key":"4455_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X, Shi S. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20:131.","journal-title":"Mol Cancer"},{"key":"4455_CR47","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398.","journal-title":"Nat Rev Cancer"},{"key":"4455_CR48","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1038\/s41467-022-30306-7","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Yong T, Wei Z, Bie N, Zhang X, Zhan G, Li J, Qin J, Yu J, Zhang B, et al. Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts. Nat Commun. 2022;13:2794.","journal-title":"Nat Commun"},{"key":"4455_CR49","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1038\/s41467-023-39035-x","volume":"14","author":"M Zhou","year":"2023","unstructured":"Zhou M, Wang J, Pan J, Wang H, Huang L, Hou B, Lai Y, Wang F, Guan Q, Wang F, et al. Nanovesicles loaded with a TGF-\u03b2 receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy. Nat Commun. 2023;14:3593.","journal-title":"Nat Commun"},{"key":"4455_CR50","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","volume":"21","author":"D Peng","year":"2022","unstructured":"Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy. Mol Cancer. 2022;21:104.","journal-title":"Mol Cancer"},{"key":"4455_CR51","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41467-024-45558-8","volume":"15","author":"EM Wenzel","year":"2024","unstructured":"Wenzel EM, Pedersen NM, Elfmark LA, Wang L, Kjos I, Stang E, Maler\u00f8d L, Brech A, Stenmark H, Raiborg C. Intercellular transfer of cancer cell invasiveness via endosome-mediated protease shedding. Nat Commun. 2024;15:1277.","journal-title":"Nat Commun"},{"key":"4455_CR52","doi-asserted-by":"publisher","first-page":"124625","DOI":"10.1016\/j.ijpharm.2024.124625","volume":"664","author":"H Wu","year":"2024","unstructured":"Wu H, Jin M, Liu Y, Wang S, Liu C, Quan X, Jin M, Gao Z, Jin Y. A self-targeting MOFs nanoplatform for treating metastatic triple-negative breast cancer through tumor microenvironment remodeling and chemotherapy potentiation. Int J Pharm. 2024;664:124625.","journal-title":"Int J Pharm"},{"key":"4455_CR53","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","volume":"56","author":"MJ Pittet","year":"2023","unstructured":"Pittet MJ, Di Pilato M, Garris C, Mempel TR. Dendritic cells as shepherds of T cell immunity in cancer. Immunity. 2023;56:2218\u201330.","journal-title":"Immunity"},{"key":"4455_CR54","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","volume":"48","author":"C Sun","year":"2018","unstructured":"Sun C, Mezzadra R, Schumacher TN. Regulation and Function of the PD-L1 Checkpoint. Immunity. 2018;48:434\u201352.","journal-title":"Immunity"},{"key":"4455_CR55","doi-asserted-by":"publisher","first-page":"161652","DOI":"10.1016\/j.cej.2025.161652","volume":"510","author":"J Wu","year":"2025","unstructured":"Wu J, Chen Z, Shang H, Tong Y, Deng W, He Y, Ba X, Zhong Z, Bai Y, Ye T, et al. Genetically engineered hybrid membrane-coated nanoparticles enable triple activation of dendritic cells for synergistic bladder cancer immunotherapy. Chem Eng J. 2025;510:161652.","journal-title":"Chem Eng J"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04455-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04455-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04455-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:06:20Z","timestamp":1781654780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04455-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4455"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04455-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments in this study were performed in line with the approved guidelines from the Committee of Animal Experimentation and the Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"559"}}